Keystone Symposia

This meeting took place in 2014

Here are the related meetings in 2020:
Cancer Epigenetics: New Mechanisms and Therapeutic Opportunities (J4)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Cancer Epigenetics (Q1)

Organizer(s) Sharon Y.R. Dent, Jean-Pierre Issa and Peter A. Jones
February 4—9, 2014
Santa Fe Community Convention Center • Santa Fe, NM USA
Discounted Abstract Deadline: Oct 15, 2013
Abstract Deadline: Nov 7, 2013
Scholarship Deadline: Oct 15, 2013
Discounted Registration Deadline: Dec 4, 2013

Sponsored by Astellas Pharma Inc., Celgene Corporation, Constellation Pharmaceuticals and Novartis Institutes for BioMedical Research

Summary of Meeting:
Epigenetic changes are now recognized to be as important to cancer formation as are gene mutations. Unlike mutations, however, epigenetic states can be altered, and epigenetic therapies hold promise as anti-cancer agents. For these approaches to succeed, we must understand how epigenetic states are created and maintained, and how they are altered in particular malignancies. This meeting will highlight large scale epigenome mapping efforts in normal cells, stem cells, and cancer cells, as well as genetic and biochemical studies focused on defining the mechanistic underpinning of these states. The meeting will bring together basic scientists studying the enzymes that govern epigenetic marks, particularly DNA methylation and histone post translational modifications, with translational and clinical researchers who are developing and implementing new epigenetic therapies. Opportunities for cross fertilization of ideas and interdisciplinary interactions will be further strengthened by joint keynote and plenary sessions with the concurrent meeting on Transcriptional Regulation.

View Meeting Program


KS/ABRCMS Travel Award Recipients

Donasian Ocan Ochola
Colorado State University, USA

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Adam Blattler
Active Motif, Inc., USA

Malaina C. Gaddis
University of Southern California, USA

E. Lorena Mora-Blanco
Lawrence Berkeley National Lab, USA

National Cancer Institute (NCI) Scholarship Recipients

Shreya Bhattacharya
St. Vincent's Institute, Australia

Chong Chen
Memorial Sloan-Kettering Cancer Center, USA

Na Li
University of Texas MD Anderson Cancer Center, USA

Sachi Nakashima Memorial Fellowship Scholarship Scholarship Recipients

Kevin D. Daze
Max Planck Institute of Immunobiology and Epigenetics, Germany

The Elkes Foundation Scholarship Recipients

Dan A. Landau
Dana-Farber Cancer Institute and the Broad Institute, USA